Walsh PC - Search Results

1

Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men.

Weber JP, Walsh PC, Peters CA, Spivak JL. Weber JP, et al. Among authors: walsh pc. Am J Hematol. 1991 Mar;36(3):190-4. doi: 10.1002/ajh.2830360306. Am J Hematol. 1991. PMID: 1705094

2

The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia.

Weber JP, Oesterling JE, Peters CA, Partin AW, Chan DW, Walsh PC. Weber JP, et al. Among authors: walsh pc. J Urol. 1989 Apr;141(4):987-92. doi: 10.1016/s0022-5347(17)41083-4. J Urol. 1989. PMID: 2467015

3

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.

Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC. Partin AW, et al. Among authors: walsh pc. J Urol. 1990 Apr;143(4):747-52. doi: 10.1016/s0022-5347(17)40079-6. J Urol. 1990. PMID: 1690309 Free article.

4

The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia.

Peters CA, Walsh PC. Peters CA, et al. Among authors: walsh pc. N Engl J Med. 1987 Sep 3;317(10):599-604. doi: 10.1056/NEJM198709033171004. N Engl J Med. 1987. PMID: 2441256

5

Unilateral nerve-sparing radical prostatectomy and hemicystectomy in management of prostate sarcoma.

Quinlan DM, Stutzman RE, Peters CA, Walsh PC. Quinlan DM, et al. Among authors: walsh pc. Urology. 1993 Apr;41(4):308-10. doi: 10.1016/0090-4295(93)90585-x. Urology. 1993. PMID: 8470313

6

Blood transfusion and anesthetic practices in radical retropubic prostatectomy.

Peters CA, Walsh PC. Peters CA, et al. Among authors: walsh pc. J Urol. 1985 Jul;134(1):81-3. doi: 10.1016/s0022-5347(17)46991-6. J Urol. 1985. PMID: 4009830

7

Longitudinal evaluation of serum androgen levels in men with and without prostate cancer.

Carter HB, Pearson JD, Metter EJ, Chan DW, Andres R, Fozard JL, Rosner W, Walsh PC. Carter HB, et al. Among authors: walsh pc. Prostate. 1995 Jul;27(1):25-31. doi: 10.1002/pros.2990270106. Prostate. 1995. PMID: 7541528

8

The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomy.

Makarov DV, Humphreys EB, Mangold LA, Carducci MA, Partin AW, Eisenberger MA, Walsh PC, Trock BJ. Makarov DV, et al. Among authors: walsh pc. J Urol. 2008 Jan;179(1):156-61; discussion 161-2. doi: 10.1016/j.juro.2007.08.133. Epub 2007 Nov 14. J Urol. 2008. PMID: 18001801 Free PMC article.

9

Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity.

Carter HB, Pearson JD, Waclawiw Z, Metter EJ, Chan DW, Guess HA, Walsh PC. Carter HB, et al. Among authors: walsh pc. Urology. 1995 Apr;45(4):591-6. doi: 10.1016/S0090-4295(99)80049-1. Urology. 1995. PMID: 7536366 Free article.

10

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease.

Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andres R, Fozard JL, Walsh PC. Carter HB, et al. Among authors: walsh pc. JAMA. 1992 Apr 22-29;267(16):2215-20. JAMA. 1992. PMID: 1372942 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

709 results

Search Page

Filters